Tenderwize
Wróć do wyszukiwania

Optimize early Hit Structures through iterative DMTA Cycles using Advanced Medicinal Chemistry

Katholieke Universiteit te Leuven·Leuven, Belgium·Expired · Aug 10, 2026·Neg W Call·Services
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Belgium – Research and experimental development services – QMMO26-4194 - Appointment of a CRO to optimize early Hit Structures through iterative DMTA Cycles (Design – Make – Test – Analysis) using Advanced Medicinal Chemistry

30/100

Ocena szansy

Needs reviewMedium complexity
ServicesExpired
Skąd ta ocena?

Szansa

30 / 100

Złożoność

50 / 100

Czynniki ryzyka

No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.

Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Services contract
  • 1 lot
  • Duration 1 YEAR
  • Perform iterative Design-Make-Test-Analyze (DMTA) cycles for optimization of early hit structures.
  • Apply advanced medicinal chemistry techniques.
Pokaż pełne podsumowanie

Single-lot negotiated procedure for appointing a Contract Research Organization (CRO) to optimize early hit structures through iterative Design-Make-Test-Analyze (DMTA) cycles in advanced medicinal chemistry. The buyer is KU Leuven, acting for itself and VIB. The contract duration is 1 year. No estimated value is provided. The procedure is a competitive negotiation without prior call (neg-w-call), likely limiting candidates to 3-4. Award criteria (price and quality) will be detailed in the second stage. The tender is published in English, with submission via the e-procurement platform. EU funding status is inconsistent: structured data indicates EU-funded, but the XML notice states no EU funds.

Ryzyka

No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.

Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • CRO must be capable of conducting advanced medicinal chemistry DMTA cycles.

Administrative

  • Electronic submission via the e-procurement platform is required.
  • Tender must be submitted in English (notice language).

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

Price (weight not specified)Quality (weight not specified)

Zamawiający

Lokalizacja

Leuven, BEL

Profil zamawiającego

Otwórz profil

Identyfikator

0419052173_5132

Działalność

Education

Części (1)

LOT-0001

Optimize early Hit Structures through iterative DMTA Cycles using Advanced Medicinal Chemistry

Appointment of a CRO to perform iterative DMTA cycles (Design-Make-Test-Analyze) for optimizing early hit structures in advanced medicinal chemistry. The contract is for services related to research and experimental development (CPV 73100000). Duration: 1 year. Place of performance: Leuven, Belgium (BE242).

ServicesEU fundedElectronic submission

Lokalizacja

BE242, Belgium

Czas trwania

1 YEAR

Kategoria

Research

Kryteria udzielenia

Best price-quality ratio

Termin

Expired Aug 10, 2026

Szczegóły zamówienia

Data publikacji
08 Jul 2026
Języki
Dutch, English

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
473822-2026

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Spain – Research and experimental development services – Pre-commercial Procurement of an innovative Systemic Sustainability Transition Solution for Health Care Organisations (suHCO)

Oct 9

Belgium – Research and development services and related consultancy services – Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases

Sep 2

France – Research and experimental development services – Chambre d’essais pour des tests en Compatibilité Electro-Magnétique (CEM) d’équipements fonctionnant à l’hydrogène

Aug 25

Belgium – Research and experimental development services – Long-term API stockpiling and rapid finished dose form manufacture

Sep 21

Norway – Research and development services and related consultancy services – Preventive conversations as a means of the police ́s preventive work.

Sep 8

Germany – Research and experimental development services – Toolkit für aktives Verteilnetzmanagement

Aug 31